COVID-19: For information related to COVID-19 (formerly referred to as “novel coronavirus"), visit

VCU Massey Cancer Center


News center

Exciting things are happening every day at VCU Massey Cancer Center. We’re saving lives and reducing suffering from cancer. We’re discovering new and better ways to prevent, diagnose and treat cancer. We’re offering opportunities for the community to join us in the progress against cancer.

Check out our latest discoveries and breaking news below. If you would like to receive our news in real-time, please follow us on social media and/or subscribe to our Ray of Hope e-newsletter.


Updates to outpatient care at Massey due to COVID-19

Stony Point [View Image]

At VCU Massey Cancer Center we have implemented changes in our clinics to mitigate the coronavirus (COVID-19) situation and keep our patients and medical teams safe.

Continue reading →

Massey director Dr. Robert Winn part of AACR Congressional briefing on cancer disparities

Today, the American Association of Cancer Research (AACR) released its inaugural Cancer Disparities Progress Report, which outlines the enormous toll that cancer exacts on racial and ethnic minorities and other underserved populations, highlights areas of progress in reducing these disparities and provides specific recommendations for achieving health equity. As a member of the AACR Steering Committee that contributed to the report, VCU Massey Cancer Center Director Robert Winn, M.D., was part of a virtual Congressional briefing on the findings.

Continue reading →

Massey researcher receives University Award of Excellence at VCU

VCU Massey Cancer Center researcher Nicholas Farrell, Ph.D., received the University Award of Excellence during VCU’s annual Faculty Convocation ceremony on September 10. VCU President Michael Rao, Ph.D., acknowledged that the six faculty members honored with various awards during the ceremony embody the university’s mission and are actively working to transform lives, despite the challenges facing the university and the nation.

Continue reading →

National clinical trial open at Massey will examine short- and long-term outcomes of patients with COVID-19 and cancer

A nationwide clinical trial funded by the National Cancer Institute and now open at VCU Massey Cancer Center will examine the short- and long-term outcomes of patients with COVID-19 and cancer to gain a more comprehensive understanding of the impacts of infection. The NCI COVID-19 in Cancer Patients Study (N-CCaPS) is a longitudinal natural history study that will include a national registry of blood samples and radiologic images from adult cancer patients infected with the novel coronavirus to analyze disease pathology.

Continue reading →

Massey researcher awarded $465,000 to investigate HPV, head and neck cancers

VCU Massey Cancer Center researcher Larisa Litovchick, M.D., Ph.D., was recently awarded $465,000 from the National Institute of Dental and Cranial Research to further investigate how human papillomavirus (HPV) leads to head and neck cancers. Findings may aid the development of novel targeted treatments.

Continue reading →

Experimental drug being developed to thwart pancreatic cancer and other KRAS-driven tumors

In his previous role at Moffitt Cancer Center, Said Sebti, Ph.D., the associate director for basic research at VCU Massey Cancer Center, and his collaborators discovered a novel drug called FGTI-2734 that overcomes a major hurdle in halting the growth of malignant tumors driven by the cancer-causing KRAS protein, including pancreatic cancer. In collaboration with Massey researchers and the Medicines for All Institute (M4ALL) at VCU, Sebti intends to further develop FGTI-2734 at Massey in an effort to eventually gain FDA approval for testing the drug in clinical trials.

Continue reading →

View graphic version